Guggenheim Capital’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-37,290	Closed	-$88K	–	2504
2018 Q1	$88K	Buy	37,290 +3,323	+10%	+$7.79K	﹤0.01%	2669
2017 Q4	$63K	Sell	33,967 -5,525	-14%	-$12.1K	﹤0.01%	2626
2017 Q3	$98K	Buy	39,492 +1,788	+5%	+$4.43K	﹤0.01%	2654
2017 Q2	$103K	Buy	37,704 +62	+0.2%	+$173	﹤0.01%	2694
2017 Q1	$113K	Buy	37,642 +83	+0.2%	+$236	﹤0.01%	2682
2016 Q4	$119K	Buy	37,559 +77	+0.2%	+$236	﹤0.01%	2754
2016 Q3	$128K	Buy	37,482 +9,339	+33%	+$25.8K	﹤0.01%	2708
2016 Q2	$64K	Buy	28,143 +927	+3%	+$2.27K	﹤0.01%	2767
2016 Q1	$69K	Buy	27,216 +4,771	+21%	+$10.6K	﹤0.01%	2786
2015 Q4	$74K	Buy	22,445 +685	+3%	+$2.05K	﹤0.01%	2864
2015 Q3	$52K	Sell	21,760 -636	-3%	-$1.65K	﹤0.01%	2852
2015 Q2	$65K	Sell	22,396 -283	-1%	-$1.1K	﹤0.01%	2940
2015 Q1	$91K	Buy	22,679 +3,275	+17%	+$11.3K	﹤0.01%	2868
2014 Q4	$58K	Buy	19,404 +2,070	+12%	+$5.6K	﹤0.01%	2904
2014 Q3	$44K	Sell	17,334 -13,954	-45%	-$33.6K	﹤0.01%	2935
2014 Q2	$77K	Sell	31,288 -880	-3%	-$1.99K	﹤0.01%	3034
2014 Q1	$86K	Buy	+32,168	New	+$94.7K	﹤0.01%	3051
2013 Q3	–	Sell	-23,694	Closed	-$76K	–	3135
2013 Q2	$76K	Buy	+23,694	New	+$75.9K	﹤0.01%	2856